水虫薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Athlete's Foot Medication Market Insights, Forecast to 2028

• レポートコード：QY2207E10364 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の水虫薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に水虫薬の世界市場のxxx％を占める「クロトリマゾール」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「子供用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の水虫薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの水虫薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの水虫薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 水虫薬のグローバル主要メーカーには、Novartis、Perrigo、Mylan、Glenmark、Taro、Novitium、Strides Pharma、Tevaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 水虫薬市場は、種類と用途によって区分されます。世界の水虫薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 クロトリマゾール、エコナゾール、ケトコナゾール、ミコナゾール、テルビナフィン、スルコナゾール 【用途別セグメント】 子供用、大人用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 水虫薬製品概要 - 種類別市場（クロトリマゾール、エコナゾール、ケトコナゾール、ミコナゾール、テルビナフィン、スルコナゾール） - 用途別市場（子供用、大人用） - 調査の目的 ・エグゼクティブサマリー - 世界の水虫薬販売量予測2017-2028 - 世界の水虫薬売上予測2017-2028 - 水虫薬の地域別販売量 - 水虫薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別水虫薬販売量 - 主要メーカー別水虫薬売上 - 主要メーカー別水虫薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（クロトリマゾール、エコナゾール、ケトコナゾール、ミコナゾール、テルビナフィン、スルコナゾール） - 水虫薬の種類別販売量 - 水虫薬の種類別売上 - 水虫薬の種類別価格 ・用途別市場規模（子供用、大人用） - 水虫薬の用途別販売量 - 水虫薬の用途別売上 - 水虫薬の用途別価格 ・北米市場 - 北米の水虫薬市場規模（種類別、用途別） - 主要国別の水虫薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの水虫薬市場規模（種類別、用途別） - 主要国別の水虫薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の水虫薬市場規模（種類別、用途別） - 主要国別の水虫薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の水虫薬市場規模（種類別、用途別） - 主要国別の水虫薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの水虫薬市場規模（種類別、用途別） - 主要国別の水虫薬市場規模（トルコ、サウジアラビア） ・企業情報 Novartis、Perrigo、Mylan、Glenmark、Taro、Novitium、Strides Pharma、Teva ・産業チェーン及び販売チャネル分析 - 水虫薬の産業チェーン分析 - 水虫薬の原材料 - 水虫薬の生産プロセス - 水虫薬の販売及びマーケティング - 水虫薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 水虫薬の産業動向 - 水虫薬のマーケットドライバー - 水虫薬の課題 - 水虫薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Athlete’s Foot Medication Market
The global Athlete’s Foot Medication market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Clotrimazole accounting for % of the Athlete’s Foot Medication global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Children segment is altered to an % CAGR throughout this forecast period.
China Athlete’s Foot Medication market size is valued at US$ million in 2021, while the North America and Europe Athlete’s Foot Medication are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Athlete’s Foot Medication landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Athlete’s Foot Medication market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Athlete’s Foot Medication market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Athlete’s Foot Medication market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Athlete’s Foot Medication market.
Global Athlete’s Foot Medication Scope and Market Size
Athlete’s Foot Medication market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Athlete’s Foot Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Clotrimazole
Econazole
Ketoconazole
Miconazole
Terbinafine
Sulconazole
Segment by Application
Children
Adult
By Company
Novartis
Perrigo
Mylan
Glenmark
Taro
Novitium
Strides Pharma
Teva
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Athlete’s Foot Medication Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Clotrimazole
1.2.3 Econazole
1.2.4 Ketoconazole
1.2.5 Miconazole
1.2.6 Terbinafine
1.2.7 Sulconazole
1.3 Market by Application
1.3.1 Global Athlete’s Foot Medication Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Athlete’s Foot Medication Market Perspective (2017-2028)
2.2 Athlete’s Foot Medication Growth Trends by Region
2.2.1 Athlete’s Foot Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Athlete’s Foot Medication Historic Market Size by Region (2017-2022)
2.2.3 Athlete’s Foot Medication Forecasted Market Size by Region (2023-2028)
2.3 Athlete’s Foot Medication Market Dynamics
2.3.1 Athlete’s Foot Medication Industry Trends
2.3.2 Athlete’s Foot Medication Market Drivers
2.3.3 Athlete’s Foot Medication Market Challenges
2.3.4 Athlete’s Foot Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Athlete’s Foot Medication Players by Revenue
3.1.1 Global Top Athlete’s Foot Medication Players by Revenue (2017-2022)
3.1.2 Global Athlete’s Foot Medication Revenue Market Share by Players (2017-2022)
3.2 Global Athlete’s Foot Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Athlete’s Foot Medication Revenue
3.4 Global Athlete’s Foot Medication Market Concentration Ratio
3.4.1 Global Athlete’s Foot Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Athlete’s Foot Medication Revenue in 2021
3.5 Athlete’s Foot Medication Key Players Head office and Area Served
3.6 Key Players Athlete’s Foot Medication Product Solution and Service
3.7 Date of Enter into Athlete’s Foot Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Athlete’s Foot Medication Breakdown Data by Type
4.1 Global Athlete’s Foot Medication Historic Market Size by Type (2017-2022)
4.2 Global Athlete’s Foot Medication Forecasted Market Size by Type (2023-2028)
5 Athlete’s Foot Medication Breakdown Data by Application
5.1 Global Athlete’s Foot Medication Historic Market Size by Application (2017-2022)
5.2 Global Athlete’s Foot Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Athlete’s Foot Medication Market Size (2017-2028)
6.2 North America Athlete’s Foot Medication Market Size by Type
6.2.1 North America Athlete’s Foot Medication Market Size by Type (2017-2022)
6.2.2 North America Athlete’s Foot Medication Market Size by Type (2023-2028)
6.2.3 North America Athlete’s Foot Medication Market Share by Type (2017-2028)
6.3 North America Athlete’s Foot Medication Market Size by Application
6.3.1 North America Athlete’s Foot Medication Market Size by Application (2017-2022)
6.3.2 North America Athlete’s Foot Medication Market Size by Application (2023-2028)
6.3.3 North America Athlete’s Foot Medication Market Share by Application (2017-2028)
6.4 North America Athlete’s Foot Medication Market Size by Country
6.4.1 North America Athlete’s Foot Medication Market Size by Country (2017-2022)
6.4.2 North America Athlete’s Foot Medication Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Athlete’s Foot Medication Market Size (2017-2028)
7.2 Europe Athlete’s Foot Medication Market Size by Type
7.2.1 Europe Athlete’s Foot Medication Market Size by Type (2017-2022)
7.2.2 Europe Athlete’s Foot Medication Market Size by Type (2023-2028)
7.2.3 Europe Athlete’s Foot Medication Market Share by Type (2017-2028)
7.3 Europe Athlete’s Foot Medication Market Size by Application
7.3.1 Europe Athlete’s Foot Medication Market Size by Application (2017-2022)
7.3.2 Europe Athlete’s Foot Medication Market Size by Application (2023-2028)
7.3.3 Europe Athlete’s Foot Medication Market Share by Application (2017-2028)
7.4 Europe Athlete’s Foot Medication Market Size by Country
7.4.1 Europe Athlete’s Foot Medication Market Size by Country (2017-2022)
7.4.2 Europe Athlete’s Foot Medication Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Athlete’s Foot Medication Market Size (2017-2028)
8.2 Asia-Pacific Athlete’s Foot Medication Market Size by Type
8.2.1 Asia-Pacific Athlete’s Foot Medication Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Athlete’s Foot Medication Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Athlete’s Foot Medication Market Share by Type (2017-2028)
8.3 Asia-Pacific Athlete’s Foot Medication Market Size by Application
8.3.1 Asia-Pacific Athlete’s Foot Medication Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Athlete’s Foot Medication Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Athlete’s Foot Medication Market Share by Application (2017-2028)
8.4 Asia-Pacific Athlete’s Foot Medication Market Size by Region
8.4.1 Asia-Pacific Athlete’s Foot Medication Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Athlete’s Foot Medication Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Athlete’s Foot Medication Market Size (2017-2028)
9.2 Latin America Athlete’s Foot Medication Market Size by Type
9.2.1 Latin America Athlete’s Foot Medication Market Size by Type (2017-2022)
9.2.2 Latin America Athlete’s Foot Medication Market Size by Type (2023-2028)
9.2.3 Latin America Athlete’s Foot Medication Market Share by Type (2017-2028)
9.3 Latin America Athlete’s Foot Medication Market Size by Application
9.3.1 Latin America Athlete’s Foot Medication Market Size by Application (2017-2022)
9.3.2 Latin America Athlete’s Foot Medication Market Size by Application (2023-2028)
9.3.3 Latin America Athlete’s Foot Medication Market Share by Application (2017-2028)
9.4 Latin America Athlete’s Foot Medication Market Size by Country
9.4.1 Latin America Athlete’s Foot Medication Market Size by Country (2017-2022)
9.4.2 Latin America Athlete’s Foot Medication Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Athlete’s Foot Medication Market Size (2017-2028)
10.2 Middle East & Africa Athlete’s Foot Medication Market Size by Type
10.2.1 Middle East & Africa Athlete’s Foot Medication Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Athlete’s Foot Medication Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Athlete’s Foot Medication Market Share by Type (2017-2028)
10.3 Middle East & Africa Athlete’s Foot Medication Market Size by Application
10.3.1 Middle East & Africa Athlete’s Foot Medication Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Athlete’s Foot Medication Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Athlete’s Foot Medication Market Share by Application (2017-2028)
10.4 Middle East & Africa Athlete’s Foot Medication Market Size by Country
10.4.1 Middle East & Africa Athlete’s Foot Medication Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Athlete’s Foot Medication Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Athlete’s Foot Medication Introduction
11.1.4 Novartis Revenue in Athlete’s Foot Medication Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Perrigo
11.2.1 Perrigo Company Details
11.2.2 Perrigo Business Overview
11.2.3 Perrigo Athlete’s Foot Medication Introduction
11.2.4 Perrigo Revenue in Athlete’s Foot Medication Business (2017-2022)
11.2.5 Perrigo Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Athlete’s Foot Medication Introduction
11.3.4 Mylan Revenue in Athlete’s Foot Medication Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 Glenmark
11.4.1 Glenmark Company Details
11.4.2 Glenmark Business Overview
11.4.3 Glenmark Athlete’s Foot Medication Introduction
11.4.4 Glenmark Revenue in Athlete’s Foot Medication Business (2017-2022)
11.4.5 Glenmark Recent Developments
11.5 Taro
11.5.1 Taro Company Details
11.5.2 Taro Business Overview
11.5.3 Taro Athlete’s Foot Medication Introduction
11.5.4 Taro Revenue in Athlete’s Foot Medication Business (2017-2022)
11.5.5 Taro Recent Developments
11.6 Novitium
11.6.1 Novitium Company Details
11.6.2 Novitium Business Overview
11.6.3 Novitium Athlete’s Foot Medication Introduction
11.6.4 Novitium Revenue in Athlete’s Foot Medication Business (2017-2022)
11.6.5 Novitium Recent Developments
11.7 Strides Pharma
11.7.1 Strides Pharma Company Details
11.7.2 Strides Pharma Business Overview
11.7.3 Strides Pharma Athlete’s Foot Medication Introduction
11.7.4 Strides Pharma Revenue in Athlete’s Foot Medication Business (2017-2022)
11.7.5 Strides Pharma Recent Developments
11.8 Teva
11.8.1 Teva Company Details
11.8.2 Teva Business Overview
11.8.3 Teva Athlete’s Foot Medication Introduction
11.8.4 Teva Revenue in Athlete’s Foot Medication Business (2017-2022)
11.8.5 Teva Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Athlete's Foot Medication Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Clotrimazole
Table 3. Key Players of Econazole
Table 4. Key Players of Ketoconazole
Table 5. Key Players of Miconazole
Table 6. Key Players of Terbinafine
Table 7. Key Players of Sulconazole
Table 8. Global Athlete's Foot Medication Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Athlete's Foot Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Athlete's Foot Medication Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Athlete's Foot Medication Market Share by Region (2017-2022)
Table 12. Global Athlete's Foot Medication Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Athlete's Foot Medication Market Share by Region (2023-2028)
Table 14. Athlete's Foot Medication Market Trends
Table 15. Athlete's Foot Medication Market Drivers
Table 16. Athlete's Foot Medication Market Challenges
Table 17. Athlete's Foot Medication Market Restraints
Table 18. Global Athlete's Foot Medication Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Athlete's Foot Medication Revenue Share by Players (2017-2022)
Table 20. Global Top Athlete's Foot Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Athlete's Foot Medication as of 2021)
Table 21. Ranking of Global Top Athlete's Foot Medication Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Athlete's Foot Medication Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Athlete's Foot Medication Product Solution and Service
Table 25. Date of Enter into Athlete's Foot Medication Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Athlete's Foot Medication Revenue Market Share by Type (2017-2022)
Table 29. Global Athlete's Foot Medication Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Athlete's Foot Medication Revenue Market Share by Type (2023-2028)
Table 31. Global Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Athlete's Foot Medication Revenue Share by Application (2017-2022)
Table 33. Global Athlete's Foot Medication Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Athlete's Foot Medication Revenue Share by Application (2023-2028)
Table 35. North America Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Athlete's Foot Medication Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Athlete's Foot Medication Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Athlete's Foot Medication Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Athlete's Foot Medication Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Athlete's Foot Medication Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Athlete's Foot Medication Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Athlete's Foot Medication Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Athlete's Foot Medication Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Athlete's Foot Medication Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Athlete's Foot Medication Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Athlete's Foot Medication Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Athlete's Foot Medication Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Athlete's Foot Medication Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Athlete's Foot Medication Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Athlete's Foot Medication Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Athlete's Foot Medication Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Athlete's Foot Medication Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Athlete's Foot Medication Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Athlete's Foot Medication Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Athlete's Foot Medication Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Athlete's Foot Medication Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Athlete's Foot Medication Market Size by Country (2023-2028) & (US$ Million)
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Novartis Athlete's Foot Medication Product
Table 68. Novartis Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 69. Novartis Recent Developments
Table 70. Perrigo Company Details
Table 71. Perrigo Business Overview
Table 72. Perrigo Athlete's Foot Medication Product
Table 73. Perrigo Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 74. Perrigo Recent Developments
Table 75. Mylan Company Details
Table 76. Mylan Business Overview
Table 77. Mylan Athlete's Foot Medication Product
Table 78. Mylan Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 79. Mylan Recent Developments
Table 80. Glenmark Company Details
Table 81. Glenmark Business Overview
Table 82. Glenmark Athlete's Foot Medication Product
Table 83. Glenmark Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 84. Glenmark Recent Developments
Table 85. Taro Company Details
Table 86. Taro Business Overview
Table 87. Taro Athlete's Foot Medication Product
Table 88. Taro Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 89. Taro Recent Developments
Table 90. Novitium Company Details
Table 91. Novitium Business Overview
Table 92. Novitium Athlete's Foot Medication Product
Table 93. Novitium Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 94. Novitium Recent Developments
Table 95. Strides Pharma Company Details
Table 96. Strides Pharma Business Overview
Table 97. Strides Pharma Athlete's Foot Medication Product
Table 98. Strides Pharma Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 99. Strides Pharma Recent Developments
Table 100. Teva Company Details
Table 101. Teva Business Overview
Table 102. Teva Athlete's Foot Medication Product
Table 103. Teva Revenue in Athlete's Foot Medication Business (2017-2022) & (US$ Million)
Table 104. Teva Recent Developments
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Athlete's Foot Medication Market Share by Type: 2021 VS 2028
Figure 2. Clotrimazole Features
Figure 3. Econazole Features
Figure 4. Ketoconazole Features
Figure 5. Miconazole Features
Figure 6. Terbinafine Features
Figure 7. Sulconazole Features
Figure 8. Global Athlete's Foot Medication Market Share by Application: 2021 VS 2028
Figure 9. Children Case Studies
Figure 10. Adult Case Studies
Figure 11. Athlete's Foot Medication Report Years Considered
Figure 12. Global Athlete's Foot Medication Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Athlete's Foot Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Athlete's Foot Medication Market Share by Region: 2021 VS 2028
Figure 15. Global Athlete's Foot Medication Market Share by Players in 2021
Figure 16. Global Top Athlete's Foot Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Athlete's Foot Medication as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Athlete's Foot Medication Revenue in 2021
Figure 18. North America Athlete's Foot Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Athlete's Foot Medication Market Size Market Share by Type (2017-2028)
Figure 20. North America Athlete's Foot Medication Market Size Market Share by Application (2017-2028)
Figure 21. North America Athlete's Foot Medication Market Size Share by Country (2017-2028)
Figure 22. United States Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Athlete's Foot Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Athlete's Foot Medication Market Size Market Share by Type (2017-2028)
Figure 26. Europe Athlete's Foot Medication Market Size Market Share by Application (2017-2028)
Figure 27. Europe Athlete's Foot Medication Market Size Share by Country (2017-2028)
Figure 28. Germany Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Athlete's Foot Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Athlete's Foot Medication Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Athlete's Foot Medication Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Athlete's Foot Medication Market Size Share by Region (2017-2028)
Figure 38. China Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Athlete's Foot Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Athlete's Foot Medication Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Athlete's Foot Medication Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Athlete's Foot Medication Market Size Share by Country (2017-2028)
Figure 48. Mexico Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Athlete's Foot Medication Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Athlete's Foot Medication Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Athlete's Foot Medication Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Athlete's Foot Medication Market Size Share by Country (2017-2028)
Figure 54. Turkey Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Athlete's Foot Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 58. Perrigo Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 59. Mylan Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 60. Glenmark Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 61. Taro Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 62. Novitium Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 63. Strides Pharma Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 64. Teva Revenue Growth Rate in Athlete's Foot Medication Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---